Thursday, October 13, 2022

"Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors"

"Overall, these results suggest painful bladder syndrome as a new possible indication for sEHI, opening a new range of applications for them in the visceral pain field."

Link via Hammock BD

No comments:

Post a Comment

Please don't comment here. Go to https://tuckergoodrich.substack.com.

Note: Only a member of this blog may post a comment.